Shares of icad inc. (NASDAQ:ICAD - Get Free Report) crossed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $2.78 and traded as high as $3.78. icad shares last traded at $3.75, with a volume of 166,301 shares changing hands.
Wall Street Analyst Weigh In
Several analysts recently commented on ICAD shares. BTIG Research lowered shares of icad from a "buy" rating to a "neutral" rating in a research report on Wednesday, April 16th. Craig Hallum lowered shares of icad from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, April 16th. Laidlaw restated a "hold" rating on shares of icad in a research report on Thursday, April 17th. Finally, Wall Street Zen started coverage on shares of icad in a research report on Tuesday, May 20th. They set a "sell" rating on the stock.
Read Our Latest Research Report on icad
icad Stock Down 0.8%
The company has a market cap of $105.21 million, a price-to-earnings ratio of -20.16 and a beta of 1.38. The company's 50-day moving average is $3.69 and its 200 day moving average is $2.81.
icad (NASDAQ:ICAD - Get Free Report) last posted its quarterly earnings data on Tuesday, May 13th. The technology company reported ($0.02) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.06) by $0.04. The business had revenue of $4.87 million for the quarter, compared to the consensus estimate of $4.54 million. icad had a negative net margin of 26.63% and a negative return on equity of 15.03%.
Hedge Funds Weigh In On icad
Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Connor Clark & Lunn Investment Management Ltd. purchased a new position in icad during the first quarter valued at $40,000. Goldman Sachs Group Inc. purchased a new position in icad during the first quarter valued at $44,000. PKS Advisory Services LLC purchased a new position in icad during the fourth quarter valued at $53,000. Cubist Systematic Strategies LLC purchased a new position in icad during the first quarter valued at $71,000. Finally, Wells Fargo & Company MN lifted its holdings in icad by 51.3% during the fourth quarter. Wells Fargo & Company MN now owns 39,542 shares of the technology company's stock valued at $72,000 after purchasing an additional 13,402 shares in the last quarter. 24.61% of the stock is owned by hedge funds and other institutional investors.
About icad
(
Get Free Report)
iCAD, Inc engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Detection and Therapy. The company provides ProFound AI for digital breast tomosynthesis and 2D mammography; PowerLook, a density assessment solution; and ProFound Risk, a breast cancer risk analysis.
Read More
Before you consider icad, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and icad wasn't on the list.
While icad currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
